Inhibition of human interleukin-12 production by pentoxifylline.

TitleInhibition of human interleukin-12 production by pentoxifylline.
Publication TypeJournal Article
Year of Publication1997
AuthorsMoller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, Karp CL
Date Published1997 Jun
KeywordsCell Culture Techniques, Dexamethasone, Dose-Response Relationship, Drug, Humans, Indomethacin, Interleukin-10, Interleukin-12, Leukocytes, Mononuclear, Monocytes, Pentoxifylline, RNA, Messenger, Transforming Growth Factor beta

Pharmacological control of interleukin-12 (IL-12) production may be a key therapeutic strategy for modulating immunological diseases dominated by type-1 cytokine responses. In this study, we investigated the effects of pentoxifylline on the production of IL-12 by human blood mononuclear cells and primary human monocytes stimulated with heat-killed Staphylococcus aureus Cowan strain I (SAC) or lipopolysaccharide (LPS). Pentoxifylline potently suppressed production of IL-12 in a concentration-dependent manner. In these same experiments, tumour necrosis factor-alpha (TNF-alpha) production was inhibited and IL-10 and prostaglandin E2 (PGE2) production was enhanced by treatment with pentoxifylline. Suppression of IL-12 production by pentoxifylline was found to be independent of several known endogenous inhibitors of IL-12, such as IL-10, transforming growth factor-beta (TGF-beta), IL-4 and PGE2. RNase protection assays revealed that pentoxifylline inhibited accumulation of both IL-12 p40 and p35 mRNA, suggesting a predominant mRNA locus for pentoxifylline-induced IL-12 inhibition. Low levels of pentoxifylline added to the suppression of IL-12 production by suboptimal inhibiting doses of dexamethasone, suggesting that this drug combination may have therapeutic utility. These results provide a firm rationale for the use of pentoxifylline in clinical trials of immunological disorders characterized by inappropriate type-1 immune responses.

Alternate JournalImmunology
PubMed ID9227317
PubMed Central IDPMC1363847
Grant ListAI-01223 / AI / NIAID NIH HHS / United States
HL-56065 / HL / NHLBI NIH HHS / United States
P01 HL 49545 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587